Considering our previous observations on VIM promoter methylation in BlCa and its association with disease aggressiveness, we sought to characterize in depth the epigenetic mechanisms putatively responsible for VIM switch in this tumour model and ascertain the relevance of VIM expression deregulation for BlCa progression. This evidence concerns the gene VIM and bladder transitional cell carcinoma.